Gut bacteria strains could be the key to predicting cancer treatment success

FHS
March 7, 2024
2:46 am

Researchers discovered that gut microbiota strains can predict the effectiveness and adverse effects of immune checkpoint blockade (ICB) therapy in rare cancer patients.

Novel treatment for polycythemia vera shows promise in clinical trial

A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this

February 22, 2024

Precision and TG Therapeutics conclude Azer-Cel license deal

Share this article Azercabtagene Zapreleucel will be developed for autoimmune diseases and other non-cancer indications. Credit: Peakstock / Shutterstock.com. Precision Biosciences and TG Therapeutics have

January 10, 2024

Aurinia fails to find buyer, will shed pipeline to focus on Lupkynis

Aurinia Pharmaceuticals said it was unable to attract any formal offers during its strategic review process, which began last summer after calls from shareholders MKT

February 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.